AUG 11, 2019 7:46 AM PDT

A Food Additive Could Make Your Cat Hypoallergenic

WRITTEN BY: Amanda Mikyska

Pixabay Images

 

With 10-30% of the population reporting sensitivity to cat dander, you probably know someone with a cat allergy.  That's why scientists at Nestlé Purina PetCare Company are developing a food additive that neutralizes a protein, Fel d1, which is responsible for 95% of allergic reactions to cats.

Fel d1 is a protein produced in cats' saliva, skin, and urine that causes almost all allergic reactions in humans.  The protein is transported from the saliva to the cat's fur when they clean themselves.  It is further transported after dandruff falls off the cat, onto other surfaces.  The approach at Purina is to develop an additive to cat food that will bind with Fel d1 proteins so the protein cannot bind to antibodies in humans.  Once the protein is occupied with the food additive, it cannot irritate human immune cells.

Purina conducted a small trial with 20 cats on a strictly controlled diet, and 11 people allergic to cats.  For one week the cats were fed the same diet to regulate their Fel d1 production, then half of the cats received the Fel d1-neutralizing food additive for an additional four weeks.  People exposed to the cats after the four-week-long special diet did not experience symptoms as severe as exposure before the diet.  It is unclear if the food additive is a long term solution because Fel d1 is a "sticky" protein, meaning it accumulates over time.

Fel d1 protein structure from Bonnet et al.

 

Humans are the only species affected by the Fel d1 protein, which makes testing solutions to the irritant a challenge.  Scientists do not want to eliminate the protein production in cats because the function of Fel d1 is unknown, and could be tied to other important pathways.  Developing a neutralizing food additive will allow the cats to continue producing the protein as normal, but about half of the protein produced will be undetected by the human immune system.  Reducing the number of antigens that irritate human immune cells would reduce the frequency and severity of allergic reactions to cats.  

Purina is hardly the first to try and develop a solution to cat allergies.  Another new solution to severe cat allergies is exposing a patient to dander incrementally.  In some patients, this method greatly reduces respiratory and skin reactions.  However, the molecular composition of dander is difficult to standardize which causes severe side effects in other patients.  Injection treatments like Allervax CAT passed clinical trials, but come with a host of side effects.  Scientists have ruled out the development of an oral medication because the medication would be metabolized before it could reach the Fel d1 antigen.     

Purina hopes to test for more long term effects, and eventually approve a cat food additive.

 

Sources: Bonnet et al., Satyaraj et al. (Purina), Satyaraj et al. (Purina), Kaiser et al., ScienceNews

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
AUG 19, 2021
Immunology
Insights Into the Interplay Between COVID and the Nasal Microbiome
AUG 19, 2021
Insights Into the Interplay Between COVID and the Nasal Microbiome
There is a spectrum of COVID symptom severity: some recover after experiencing nothing more than a mild cough, while oth ...
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
AUG 23, 2021
Cancer
A Safe and Effective Combination Therapy for Advanced Cancer
AUG 23, 2021
A Safe and Effective Combination Therapy for Advanced Cancer
Immunotherapies are emerging as a promising strategy for the treatment of late-stage cancers which currently have m ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
OCT 04, 2021
Health & Medicine
Guillain-Barre Syndrome After COVID-19 Infection
OCT 04, 2021
Guillain-Barre Syndrome After COVID-19 Infection
Researchers with the International GBS Outcome Study (IGOS) investigated newly-diagnosed GBS patients from the beginning ...
OCT 14, 2021
Genetics & Genomics
RSV Infections Can Modify Host Immune Gene Activity
OCT 14, 2021
RSV Infections Can Modify Host Immune Gene Activity
Respiratory syncytial virus (RSV) are thought to be incredibly common; research has suggested that almost everyone is ev ...
Loading Comments...